Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26378747.
- Also identified by DOI 10.1001/jamaophthalmol.2015.3108.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival.
Medical subject headings
- Retinal Neoplasms
- Retinoblastoma